


Soranib Tablet
Manufacturer
Cipla Ltd
Salt Composition
Sorafenib (200mg)
Key Information
Short Description
Soranib Tablet belongs to the class of medicines known as tyrosine kinase inhibitors used in the treatment of liver cancer, kidney cancer, and thyroid cancer.
Dosage Form
Tablet
Introduction
Soranib Tablet should be taken on an empty stomach but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Soranib Tablet is to be taken empty stomach.
How it works
Soranib Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Quick Tips
Take it without food or with a low fat meal and a full glass of water. Take it at the same time everyday to maintain consistent levels in your body. Women who could get pregnant should use a reliable method of contraception to prevent pregnancy while taking this medicine. Your doctor may regularly monitor your blood pressure while you are taking this medicine. Inform your doctor if you get a skin rash or any pain, swelling, and redness of your hands and feet while you are taking this medicine. Do not change the dose or discontinue use without consulting your doctor.
Related Medicines

Orib 200mg Tablet

Serixa 200mg Tablet

Soranib Tablet

Sorafav 200mg Tablet

Soratib 200mg Tablet

Serixa 200mg Tablet

Sorafekast 200mg Tablet

Sonora 200mg Tablet

Sorafekast 200mg Tablet
